Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Quotient Ltd Ord (QTNT)

Quotient Ltd Ord (QTNT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 612,193
  • Shares Outstanding, K 101,022
  • Annual Sales, $ 32,660 K
  • Annual Income, $ -102,770 K
  • 60-Month Beta 2.60
  • Price/Sales 18.90
  • Price/Cash Flow N/A
  • Price/Book 14.62
Trade QTNT with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.26
  • Number of Estimates 1
  • High Estimate -0.26
  • Low Estimate -0.26
  • Prior Year -0.37
  • Growth Rate Est. (year over year) +29.73%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.09 +19.06%
on 12/31/20
7.59 -20.16%
on 12/18/20
-1.05 (-14.71%)
since 12/15/20
3-Month
4.31 +40.60%
on 10/29/20
7.59 -20.16%
on 12/18/20
+0.98 (+19.29%)
since 10/15/20
52-Week
2.39 +153.03%
on 03/18/20
10.38 -41.62%
on 04/28/20
-2.82 (-31.76%)
since 01/15/20

Most Recent Stories

More News
Quotient Limited Wins 2021 BIG Innovation Award

Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced it has been named a winner in the prestigious 2021 BIG Innovation Awards presented by the Business...

QTNT : 6.06 (-0.82%)
Quotient Limited Announces Departure of Chief Operating Officer

Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that on December 21, 2020, Ed Farrell delivered a notice of resignation from his position as the Company's...

QTNT : 6.06 (-0.82%)
Quotient Limited Provides Status Update on the Initial SDS Microarray and MosaiQ Instrument for the US Market

Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that it received a request from the U.S. Food and Drug Administration (FDA) for additional testing...

QTNT : 6.06 (-0.82%)
Quotient Limited Announces MosaiQ(TM) Expanded IH EU Field Trial Performance Data

Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today reported preliminary EU field trial performance data for its MosaiQ Expanded Immunohematology (IH) Microarray....

QTNT : 6.06 (-0.82%)
Dow Sets New Record and Clears 30K for the First Time

Dow Sets New Record and Clears 30K for the First Time

SNA : 168.57 (-0.90%)
SSNC : 66.39 (-0.64%)
VMC : 160.92 (+0.19%)
LEN : 76.59 (+2.11%)
QTNT : 6.06 (-0.82%)
VBR : 150.76 (-1.16%)
VHT : 232.30 (+0.02%)
CCRN : 9.11 (-0.87%)
SHOP : 1,170.47 (-0.71%)
MHK : 148.97 (-1.97%)
MMM : 165.55 (-0.52%)
WHR : 194.54 (+0.87%)
JBL : 44.60 (-1.93%)
TPR : 33.62 (-1.29%)
LH : 223.71 (+1.59%)
BZH : 15.37 (-1.28%)
OSTK : 59.52 (-7.10%)
LEVI : 21.34 (-1.43%)
ATHM : 102.88 (+5.25%)
PRPL : 35.48 (-1.91%)
GDS : 105.04 (+2.16%)
AMRK : 28.52 (-1.31%)
STNE : 78.23 (-1.49%)
COP : 45.12 (-5.74%)
ELAN : 31.51 (-0.41%)
INCY : 90.56 (-1.61%)
NUAN : 48.80 (-2.81%)
ULTA : 301.85 (+0.02%)
ACM : 53.73 (-0.43%)
TCS : 11.68 (-8.75%)
AZN : 51.34 (+0.10%)
PFE : 36.70 (-0.14%)
MRNA : 129.65 (-0.05%)
FB : 251.36 (+2.33%)
AAPL : 127.14 (-1.37%)
NFLX : 497.98 (-0.58%)
GOOG : 1,736.19 (-0.23%)
Quotient Limited to Participate in Two Upcoming Conferences

Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland, today announced that the Company will participate in two upcoming...

QTNT : 6.06 (-0.82%)
Quotient (QTNT) Reports Q2 Loss, Tops Revenue Estimates

Quotient (QTNT) delivered earnings and revenue surprises of 48.57% and 105.97%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

QTNT : 6.06 (-0.82%)
Quotient Limited Reports Second Quarter Fiscal 2021 Results and Business Update

-- FDA Emergency Use Authorization for the MosaiQ COVID-19 antibody test received

QTNT : 6.06 (-0.82%)
Will Quotient (QTNT) Report Negative Earnings Next Week? What You Should Know

Quotient (QTNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

QTNT : 6.06 (-0.82%)
Quotient Limited to Report Second Quarter 2021 Financial Results and Host Conference Call

Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal second quarter ended September 30, 2020 will be released before market open...

QTNT : 6.06 (-0.82%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Quotient Limited is a commercial-stage transfusion diagnostics company. It is focused on supplying blood-grouping consumables and developing MosaiQ, a fully automated platform for use in donor centers and patient-testing sites. Quotient Limited is headquartered in Edinburgh, Scotland and Newton, Pennsylvania....

See More

Key Turning Points

3rd Resistance Point 6.41
2nd Resistance Point 6.29
1st Resistance Point 6.17
Last Price 6.06
1st Support Level 5.93
2nd Support Level 5.81
3rd Support Level 5.69

See More

52-Week High 10.38
Fibonacci 61.8% 7.33
Fibonacci 50% 6.39
Last Price 6.06
Fibonacci 38.2% 5.45
52-Week Low 2.39

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar